Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

University of Messina, Italy
Title: ADENOSINE A2A RECEPTOR AS A INNOVATIVE TARGET TO DESIGN DRUGS FOR DIABETIC ULCERS: FROM PRECLINICAL TO CLINICAL EVALUATION
Abstract

Diabetic foot ulcers are a leading cause of hospitalization. A reduced formation of new vessels and capillaries is responsible for the poor wound healing observed in diabetes. Adenosine A2A receptor plays a central role in modulating angiogenesis. PDRN (polydeoxyribonucleotide) is a DNA derived drug that engages adenosine A2A receptors. In experimental studies PDRN improved the skin repair process and enhanced wound-breaking strength in diabetic animals. This effect was supported by a marked increase in the expression of Vascular Endothelial Growth Factor (VEGF), a master regulator of angiogenesis that is impaired in diabetes-related wound disorders. The healing-promoting effect was abrogated by adenosine A2A receptor antagonist DMPX. PDRN beneficial effects were confirmed in a clinical trial. Diabetic patient with Wagner grade 1 or 2 ulcers were randomly assigned to receive placebo (n=106) or PDRN (n=110) for 8 weeks. The drug was injected daily by intramuscular route (5.625 mg in a 3 ml, vial) for 5 day/week and by perilesional route (5.625 mg, in a 3 ml vial) 2 day/week for 8 weeks. The treated group nearly doubled the rate of complete healing of difficult-to-heal diabetic foot ulcers compared to placebo as early as 8 weeks after start of treatment. This study is one of the largest trial ever carried out in diabetic patients with poor diabetic skin repair that points out a dramatic efficacy of PDRN in improving hard-to-heal chronic diabetic foot ulcers and confirms the role of adenosine A2A receptor in\ diabetes related waound healing disorders.

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by

Allied Academies Global Conference Directory

Mail us at

Drop us an email for Program enquiry
diabetes@alliedconferences.org
Sponsors/Exhibiting/Advertising
diabetes@alliedconferences.org
General Queries
diabetes@alliedconferences.org
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

  • Before 60 days of the conference: Eligible for Full Refund less $100 service Fee
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.
Copyright © 2018-2019 Allied Academies, All Rights Reserved.